NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus

被引:17
作者
Wang, Jie [1 ]
Xiao, Mengjie [1 ]
Wang, Jie [1 ]
Wang, Shudong [2 ,3 ]
Zhang, Jingjing [4 ]
Guo, Yuanfang [1 ]
Tang, Yufeng [5 ]
Gu, Junlian [1 ]
机构
[1] Shandong Univ, Sch Nursing, Cheeloo Coll Med, Jinan, Peoples R China
[2] Jilin Univ, Hosp 1, Dept Cardiol, Changchun, Peoples R China
[3] China Med Univ, Hosp 1, Dept Cardiol, Shenyang, Peoples R China
[4] Peoples Hosp Liaoning Prov, Dept Cardiol, Shenyang, Peoples R China
[5] Shandong First Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
NRF2; epigenetic modifications; activators; diabetic cardiac complication; diabetic vascular complication; APOPTOTIC CELL-DEATH; OXIDATIVE STRESS; NRF2; EXPRESSION; HIGH GLUCOSE; TRANSFORMATION; NEPHROPATHY; SULFORAPHANE; MICE; REACTIVATION; RETINOPATHY;
D O I
10.3389/fendo.2021.598005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus (DM) is a highly prevalent chronic disease that is accompanied with serious complications, especially cardiac and vascular complications. Thus, there is an urgent need to identify new strategies to treat diabetic cardiac and vascular complications. Nuclear factor erythroid 2-related factor 2 (NRF2) has been verified as a crucial target for the prevention and treatment of diabetic complications. The function of NRF2 in the treatment of diabetic complications has been widely reported, but the role of NRF2-related epigenetic modifications remains unclear. The purpose of this review is to summarize the recent advances in targeting NRF2-related epigenetic modifications in the treatment of cardiac and vascular complications associated with DM. We also discuss agonists that could potentially regulate NRF2-associated epigenetic mechanisms. This review provides a better understanding of strategies to target NRF2 to protect against DM-related cardiac and vascular complications.
引用
收藏
页数:10
相关论文
共 86 条
[1]   Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2 [J].
Alam, Md. Morshedul ;
Okazaki, Keito ;
Nguyen, Linh Thi Thao ;
Ota, Nao ;
Kitamura, Hiroshi ;
Murakami, Shohei ;
Shima, Hiroki ;
Igarashi, Kazuhiko ;
Sekine, Hiroki ;
Motohashi, Hozumi .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (18) :7519-7530
[2]   Recursive Motif Analyses Identify Brain Epigenetic Transcription Regulatory Modules [J].
Banerjee, Sharmi ;
Wei, Xiaoran ;
Xie, Hehuang .
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2019, 17 :507-515
[3]   Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway [J].
Civantos, Esther ;
Bosch, Enrique ;
Ramirez, Elisa ;
Zhenyukh, Olha ;
Egido, Jesus ;
Lorenzo, Oscar ;
Mas, Sebastian .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 :207-222
[4]   Differential expression of miRNA in rat myocardial tissues under psychological and physical stress [J].
Cui, Yan ;
Bai, Yun ;
Wang, Xiao Dong ;
Liu, Bin ;
Zhao, Zhuo ;
Wang, Li Shuang .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (04) :901-906
[5]   Identifying chondroprotective diet-derived bioactives and investigating their synergism [J].
Davidson, Rose K. ;
Green, Jonathan ;
Gardner, Sarah ;
Bao, Yongping ;
Cassidy, Aedin ;
Clark, Ian M. .
SCIENTIFIC REPORTS, 2018, 8
[6]   Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC [J].
Dong, Wenpeng ;
Jia, Ye ;
Liu, Xiuxia ;
Zhang, Huan ;
Li, Tie ;
Huang, Wenlin ;
Chen, Xudong ;
Wang, Fuchun ;
Sun, Weixia ;
Wu, Hao .
JOURNAL OF ENDOCRINOLOGY, 2017, 232 (01) :71-83
[7]   A New Road for Treating the Vascular Complications of Diabetes: So Let's Step on the Gas [J].
Evans, Joseph L. ;
Goldfine, Ira D. .
DIABETES, 2016, 65 (02) :346-348
[8]   Ginsenoside Rb1 Attenuates High Glucose-Induced Oxidative Injury via the NAD-PARP-SIRT Axis in Rat Retinal Capillary Endothelial Cells [J].
Fan, Chunlan ;
Ma, Qing ;
Xu, Meng ;
Qiao, Yuan ;
Zhang, Yi ;
Li, Pin ;
Bi, Yucong ;
Tang, Minke .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
[9]   RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability [J].
Feng, Shan ;
Zou, Li ;
Wang, Hongjin ;
He, Ran ;
Liu, Ke ;
Zhu, Huifeng .
MOLECULES, 2018, 23 (09)
[10]  
Feng XZ, 2019, AM J TRANSL RES, V11, P5664